FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

28033811000001101: Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    88684701000001115 Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    88684801000001112 Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Is a Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Has manufactured dose form Conventional release rectal suppository false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Has specific active ingredient Mesalazine false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Has dispensed dose form Suppository false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) 20 suppository Has AMP False Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start